CIPLA FDA Approval ANDA 210322

ANDA 210322

CIPLA

FDA Drug Application

Application #210322

Application Sponsors

ANDA 210322CIPLA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION0.2MG/ML0ISOPROTERENOL HYDROCHLORIDEISOPROTERENOL HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-06-12STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210322
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISOPROTERENOL HYDROCHLORIDE","activeIngredients":"ISOPROTERENOL HYDROCHLORIDE","strength":"0.2MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/12\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-06-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.